Market closed
MiNK Therapeutics/$INKT
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About MiNK Therapeutics
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.
Ticker
$INKT
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
31
Website
INKT Metrics
BasicAdvanced
$42M
-
-$3.78
0.09
-
Price and volume
Market cap
$42M
Beta
0.09
52-week high
$13.79
52-week low
$4.56
Financial strength
Current ratio
0.889
Quick ratio
0.855
Long term debt to equity
-26.271
Total debt to equity
-26.271
Management effectiveness
Return on assets (TTM)
-120.36%
Return on equity (TTM)
88.52%
Valuation
Price to book
-2.4
Price to tangible book (TTM)
-2.4
Price to free cash flow (TTM)
-3.576
Growth
Earnings per share change (TTM)
-47.88%
3-year earnings per share growth (CAGR)
-29.42%
INKT News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for MiNK Therapeutics stock?
MiNK Therapeutics (INKT) has a market cap of $42M as of February 25, 2025.
What is the P/E ratio for MiNK Therapeutics stock?
The price to earnings (P/E) ratio for MiNK Therapeutics (INKT) stock is 0 as of February 25, 2025.
Does MiNK Therapeutics stock pay dividends?
No, MiNK Therapeutics (INKT) stock does not pay dividends to its shareholders as of February 25, 2025.
When is the next MiNK Therapeutics dividend payment date?
MiNK Therapeutics (INKT) stock does not pay dividends to its shareholders.
What is the beta indicator for MiNK Therapeutics?
MiNK Therapeutics (INKT) has a beta rating of 0.09. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.